Volume : 10, Issue : 09, September – 2023
Title:
39.FORMULATION AND EVALUATION OF MELOXICAM-LOADED TRANSFERSOME GEL AS TRANSDERMAL DRUG DELIVERY CARRIERS
Authors :
Lokerevu Spoorthi Reddy , Devara Raj kumar
Abstract :
Transfersomes (TFS) are the promising carriers for transdermal delivery of various low and high molecular weight drugs, owing to their self-regulating and self-optimizing nature. Herein, we report synthesis and characterization of TFS loaded with meloxicam (MLX), a Nonsteroidal anti-inflammatory drug (NSAIDs) for transdermal delivery. The different formulations of TFS containing varying amounts of lecithin, Span 80, and Tween 80 were successfully prepared by thin-film hydration method. FTIR pre-formulation investigations conformed that there was no contact among the medication and excipients, according to the FTIR spectra. Thin film hydration was used to create the transfersome formulations, which were then added to the 1.5% Carbopol gel. The Formulation F6 has a greater entrapment efficiency and maximum drug release since it contains Lecithin: Span-80 in a ratio of 89.84 (%w/w). A greater correlation with Higuchi’s equation was discovered to fit the kinetic analysis of the transfersome gel formulation than with the zero order and first order. This claims that diffusion process was primarily responsible for the drug’s release from the lipid bilayer. According to stability studies for improved transfersome gel formulations, manufactured transfersomes are stable at room temperature. Finally, it can be inferred from the findings of the current study that transfersome gel enhances the transdermal distribution of the medication Meloxicam, prolongs the release, and improves site specificity. With the use of transfersomes, a number of medications that are difficult to administer through other methods can now be delivered safely and effectively transdermally.
Keywords: Transfersomes, NSAID, Meloxicam, lecithin, Span 80, Tween 80, Carbopol, gel.
Cite This Article:
Please cite this article in press Lokerevu Spoorthi Reddy et al, Formulation And Evaluation Of Meloxicam-Loaded Transfersome Gel As Transdermal Drug Delivery Carriers, Indo Am. J. P. Sci, 2023; 10 (09).
Number of Downloads : 10
References:
1. Sohail M. F., Shah P. A., Tariq I., et al. Development and in vitro evaluation of flurbiprofen microcapsules prepared by modified solvent evaporation technique. Tropical Journal of Pharmaceutical Research . 2014;13(7):1031–1038.
2. Mustafa Kiyani M., Sohail M. F., Shahnaz G., et al. Evaluation of turmeric nanoparticles as anti-gout agent: modernization of a traditional drug. Medicina . 2019;55(1):p. 10.
3. Bjarnason I., Scarpignato C., Holmgren E., Olszewski M., Rainsford K. D., Lanas A. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti- inflammatory drugs. Gastroenterology . 2018;154(3):500–514.
4. Zuo J., Du L., Li M., Liu B., Zhu W., Jin Y. Transdermal enhancement effect and mechanism of iontophoresis for non- steroidal anti-inflammatory drugs. International Journal of Pharmaceutics . 2014;466(1-2):76–82.
5. Ahmad Z., Khan M. I., Siddique M. I., et al. Fabrication and characterization of thiolated chitosan microneedle patch for transdermal delivery of tacrolimus. AAPS PharmSciTech . 2020;21(2):1–12.
6. Hassan S., Prakash G., Ozturk A. B., et al. Evolution and clinical translation of drug delivery nanomaterials. Nano Today . 2017;15:91–106.
7. Khan A. U., Jamshaid H., Din F. U., Zeb A., Khan G. M. Designing, optimization and characterization of trifluralin transfersomal gel to passively target cutaneous leishmaniasis. Journal of Pharmaceutical Sciences . 2022;111(6):1798–1811.
8. Batool S., Zahid F., Ud-Din F., et al. Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis: in vitro and in vivo analyses. Drug Development and Industrial Pharmacy . 2021;47(3):440–453.
9. Dar M. J., Din F. U., Khan G. M. Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell. Drug Delivery . 2018;25(1):1595–1606.
10. Cevc G. Transdermal drug delivery of insulin with ultradeformable carriers. Clinical Pharmacokinetics . 2003;42(5):461–474.
11. Fesq H., Lehmann J., Kontny A., et al. Improved risk–benefit ratio for topical triamcinolone acetonide in transfersomeR in comparison with equipotent cream and ointment: a randomized controlled trial. The British Journal of Dermatology . 2003;149(3):611–619
12. Cevc G., Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transfersomes. Biochimica et Biophysica Acta (BBA)-Biomembranes . 2001;1514(2):191–205.
13. Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Advanced Drug Delivery Reviews . 2004;56(5):675–711.
14. Salim M. W., Shabbir K., Yousaf A. M., Choi H.-G., Khan G. M. Preparation, _in-vitro_ and _in-vivo_ evaluation of rifampicin and vancomycin co-loaded transfersomal gel for the treatment of cutaneous leishmaniasis. Journal of Drug Delivery Science and Technology . 2020;60,
15. Cevc G., Mazgareanu S., Rother M. Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels. International Journal of Pharmaceutics . 2008;360(1-2):29–39.
16. Raut S., Bhadoriya S. S., Uplanchiwar V., Mishra V., Gahane A., Jain S. K. Lecithin organogel: a unique micellar system for the delivery of bioactive agents in the treatment of skin aging. Acta Pharmaceutica Sinica B . 2012;2(1):8–15.
17. Vintiloiu A., Leroux J.-C. Organogels and their use in drug delivery — a review. Journal of Controlled Release . 2008;125(3):179–192.
18. Rehman K., Zulfakar M. H. Recent advances in gel technologies for topical and transdermal drug delivery. Drug Development and Industrial Pharmacy . 2014;40(4):433–440.
19. Rabia S., Khaleeq N., Batool S., et al. Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting via topical route. Nanomedicine . 2020;15(2):183–203.
20. Abdellatif A. A., Tawfeek H. M. Transfersomal nanoparticles for enhanced transdermal delivery of clindamycin. AAPS PharmSciTech . 2016;17(5):1067–1074.